Literature DB >> 35384868

What Factors Are Associated With Postoperative Ischiofemoral Impingement After Bernese Periacetabular Osteotomy in Developmental Dysplasia of the Hip?

Ying Huang1, Zheng Zeng2, Liu-Yang Xu3, Yang Li3, Jian-Ping Peng3, Chao Shen3, Guoyan Zheng4, Xiao-Dong Chen3.   

Abstract

BACKGROUND: Any abnormal structures that contribute to the narrowing of the ischiofemoral space could induce ischiofemoral impingement. Bernese periacetabular osteotomy (PAO) medializes the hip center and, therefore, decreases contact stress on the cartilage in developmental dysplasia of the hip (DDH). However, medialization of the hip center might also narrow the ischiofemoral space, which may increase the risk of postoperative ischiofemoral impingement in patients with acetabular dysplasia who are undergoing PAO. Furthermore, the dysplastic hip has less ischiofemoral space and less space for the quadratus femoris. A few studies have focused on the amount of medialization of the hip center, but the proportion of postoperative ischiofemoral impingement after PAO has not been investigated. QUESTIONS/PURPOSES: (1) What proportion of patients develop ischiofemoral impingement after undergoing unilateral PAO for DDH? (2) What radiographic factors are associated with postoperative ischiofemoral impingement in patients who underwent PAO for DDH? (3) How much hip center medialization is safe so as to avoid postoperative ischiofemoral impingement during PAO?
METHODS: Between 2014 and 2016, we treated 265 adult patients who had symptomatic residual acetabular dysplasia (lateral center-edge angle less than 20°) using PAO. During that time, we generally offered PAO to patients with acetabular dysplasia when the patients had no advanced osteoarthritis (Tönnis grade < 2). Of those, we considered only patients who underwent primary PAO without femoral osteotomy as potentially eligible. Based on that, 65% (173 of 265) were eligible; a further 9% (24 of 265) were excluded due to leg length discrepancy, spine disorders, or joint replacement in the contralateral side, and another 6% (17 of 265) of patients were lost before the minimum study follow-up of 2 years or had incomplete datasets, leaving 50% (132 of 265) for analysis in this retrospective study at a mean of 2.70 ± 0.71 years. The diagnosis of ischiofemoral impingement was defined by symptoms, MRI, and diagnostic ischiofemoral injection. We ascertained the percentage of patients with this diagnosis to answer the first research question. To answer the second question, we divided the patients into two groups: PAO patients with ischiofemoral impingement and PAO patients without ischiofemoral impingement. The demographic data and preoperative imaging parameters of patients in both groups were compared. There were statistical differences in acetabular version, ischial angle, neck-shaft angle, the presence of positive coxa profunda sign, McKibbin index, ischiofemoral space, quadratus femoris space, anterior acetabular section angle, and the net amount of hip center medialization. To investigate potential factors associated with postoperative ischiofemoral impingement in patients who underwent PAO, these factors underwent binary logistic regression analysis. To answer the third question, the cutoff value of the net amount of hip center medialization was evaluated using receiver operator characteristic curve and the Youden index method.
RESULTS: We found that 26% (35 of 132) of PAO dysplastic hips had postoperative ischiofemoral impingement. After controlling for confounding variables such as acetabular version, ischial angle, femoral neck version, McKibbin index, and ischiofemoral space, we found that an increasing neck-shaft angle (odds ratio 1.14 [95% confidence interval 1.01 to 1.29]; p = 0.03), a positive coxa profunda sign (OR 0.13 [95% CI 0.03 to 0.58]; p < 0.01), and an increasing net amount of hip center medialization (OR 2.76 [95% CI 1.70 to 4.47]; p < 0.01) were associated with postoperative ischiofemoral impingement in patients with DDH who underwent PAO (R 2 = 0.73). The cutoff values of neck-shaft angle was 138.4°. The cutoff values of the net amount of hip center medialization was 1.9 mm.
CONCLUSIONS: Postoperative ischiofemoral impingement could occur in patients with acetabular dysplasia who have undergone PAO after hip center medialization. An increasing neck-shaft angle, a positive coxa profunda sign on preoperative imaging, and excessive medialization of the hip center are factors associated with ischiofemoral impingement development in these patients. Therefore, we suggest that physicians measure the ischiofemoral space on a preoperative CT when patients with DDH have an increasing neck-shaft angle (> 138.4°) or a positive coxa profunda sign on radiological imaging. During PAO, the amount of hip center medialization should be carefully controlled to keep these patients from developing postoperative ischiofemoral impingement. LEVEL OF EVIDENCE: Level III, therapeutic study.
Copyright © 2022 by the Association of Bone and Joint Surgeons.

Entities:  

Mesh:

Year:  2022        PMID: 35384868      PMCID: PMC9384945          DOI: 10.1097/CORR.0000000000002199

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.755


  38 in total

1.  Report of breakout session: Coxa profunda/protrusio management.

Authors:  Moritz Tannast; Michael Leunig
Journal:  Clin Orthop Relat Res       Date:  2012-12       Impact factor: 4.176

2.  Effect of angular deformities of the proximal femur on impingement-free hip range of motion in a three-dimensional rigid body model.

Authors:  Faustine Vallon; Amélie Reymond; Philipp Fürnstahl; Patrick O Zingg; Atul F Kamath; Jess Snedeker; Claudio Dora
Journal:  Hip Int       Date:  2015-06-24       Impact factor: 2.135

3.  The association between periacetabular osteotomy reorientation and hip joint reaction forces in two subgroups of acetabular dysplasia.

Authors:  Brecca M M Gaffney; John C Clohisy; Linda R Van Dillen; Michael D Harris
Journal:  J Biomech       Date:  2019-10-31       Impact factor: 2.712

4.  Impingement of the lesser trochanter on the ischial ramus after total hip arthroplasty. Report of three cases.

Authors:  K A Johnson
Journal:  J Bone Joint Surg Am       Date:  1977-03       Impact factor: 5.284

5.  Anteversion of the acetabulum and femoral neck in normals and in patients with osteoarthritis of the hip.

Authors:  O Reikerås; I Bjerkreim; A Kolbenstvedt
Journal:  Acta Orthop Scand       Date:  1983-02

6.  Ischiofemoral Impingement Syndrome: Effect of Morphological Variations on the Diagnosis.

Authors:  Ali Dablan; Cemil Oktay; Can Çevikol
Journal:  Curr Med Imaging       Date:  2021

Review 7.  Current Concepts Review: Evaluation and Management of Posterior Hip Pain.

Authors:  Juan Gómez-Hoyos; Robroy L Martin; Hal David Martin
Journal:  J Am Acad Orthop Surg       Date:  2018-09-01       Impact factor: 3.020

8.  Coxa profunda is not a useful radiographic parameter for diagnosing pincer-type femoroacetabular impingement.

Authors:  Jeffrey J Nepple; Charles L Lehmann; James R Ross; Perry L Schoenecker; John C Clohisy
Journal:  J Bone Joint Surg Am       Date:  2013-03-06       Impact factor: 5.284

9.  Valgus hip with high antetorsion causes pain through posterior extraarticular FAI.

Authors:  Klaus A Siebenrock; Simon Damian Steppacher; Pascal Cyrill Haefeli; Joseph Michael Schwab; Moritz Tannast
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

10.  Supine Versus Standing Radiographs for Detecting Ischiofemoral Impingement: A Propensity Score-Matched Analysis.

Authors:  Sunghoon Park; Hyun Young Lee; Pham Manh Cuong; Ye-Yeon Won; Hyung-Min Ji; Seung-Hyun Yoon; Kyu-Sung Kwack
Journal:  AJR Am J Roentgenol       Date:  2016-04-12       Impact factor: 3.959

View more
  1 in total

1.  CORR Insights®: What Factors Are Associated With Postoperative Ischiofemoral Impingement After Bernese Periacetabular Osteotomy in Developmental Dysplasia of the Hip?

Authors:  Khaled Emara
Journal:  Clin Orthop Relat Res       Date:  2022-04-28       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.